Alphabet Inc.'s Form 4 filing
Prime Medicine, Inc. (PRME) · filed May 10, 2023
- Accession no.
- 0001209191-23-028464
- Filed
- May 10, 2023, 4:17 PM ET
- Trade date
- May 8-9, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.95M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Alphabet Inc.CIK 0001652044 | 10% Owner |
| GV 2019 GP, L.L.C.CIK 0001845038 | 10% Owner |
| GV 2019 GP, L.P.CIK 0001845039 | 10% Owner |
| GV 2019, L.P.CIK 0001845041 | 10% Owner |
| GV 2021, L.P.CIK 0001861202 | 10% Owner |
| GV 2021 GP, L.L.C.CIK 0001861206 | 10% Owner |
| GV 2021 GP, L.P.CIK 0001861216 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2023 | Common Stock | SSaleDisposed | −100,772 | $14.13 | −$1,423,726.97 | 11,421,476 | Indirect | |
| May 9, 2023 | Common Stock | SSaleDisposed | −321,238 | $14.08 | −$4,522,613.43 | 11,100,238 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.